Skip to main content

The shelf is
in Yorkshire.

Viper keeps real stock here in the UK, so availability is clear, dispatch is fast and you know exactly where your order is coming from.

Why we hold stock

Holding stock costs more, but it gives us control over the things that matter: availability, dispatch and what actually leaves our door.

Viper buys ahead, keeps stock in our own UK unit and fulfils orders ourselves. If something is shown as available, it is physically here and ready to be packed.

We are a specialist supplier, not a manufacturer, and we are clear about that. We set our sourcing standards, maintain batch traceability and publish supporting analysis where it is available.

Manufacturer to shelf to you.

A simple supply chain, with clear standards at each stage.

We buy ahead, receive stock into our own UK unit and only release material into saleable inventory once it meets our acceptance requirements.

  1. Before the order

    We set the specification

    Each product is sourced against defined requirements covering identity, minimum purity and the documentation expected with the batch.

  2. On arrival

    It comes to Viper

    Stock is received into our own UK unit, checked in and assigned to inventory. Nothing shown as Viper stock is being fulfilled from somebody else’s shelf.

  3. If it falls short

    It is written off

    Material that does not meet our acceptance requirements is removed from saleable stock and written off. It is not relabelled as a lower grade or quietly passed on to customers.

  4. On dispatch

    Picked from our shelf

    Your order is picked from Viper-held stock, checked against the product and batch, packed here in the UK and sent by tracked delivery.

99%+

The standard we source to

Every listed peptide is purchased against a minimum 99% purity specification. Where independent analysis is available, we publish the actual result for that specific batch, so the data you see is the data the laboratory reported.

What the documentation tells you

Batch documentation is there to give you useful information about the specific material it relates to, not a generic certificate attached to an entire product line.

Specific to the batch
A published certificate relates to the sample and batch identified on the report. Results from one batch are never presented as evidence for another.
Published where available
Our independent analysis programme covers an increasing part of the Viper range. Where batch-specific documentation is available, we publish it. Where it isn’t, we say so clearly.
Traceable references
Published documentation is linked to the relevant Viper batch reference, making it straightforward to match the material you hold with the information available for it.
Results, without overclaiming
We publish what the laboratory reports. Purity, identity and other results are described according to the methods actually performed, without extending those findings beyond what the analysis supports.

Research means research

Viper supplies materials for laboratory and analytical research. That distinction shapes how we describe products, how we support customers and what information we publish.

No human or veterinary use guidance
We do not provide dosing, administration or treatment guidance for people or animals.
No therapeutic claims
Research findings are presented as research. We do not turn them into claims about what a Viper product will do for a person.
Clear research-use boundaries
Products supplied for research use are not marketed as medicines, supplements or consumer health products.
Straightforward support
Our team can help with orders, stock, batches, documentation and product specifications while staying within those research-use boundaries.

Read our full Research Use Only Policy and Medical & Health Claims Policy.

Know what you’re buying.

Ask us about current stock, the batch being supplied, available documentation or product specifications before you place an order.